Prevalence and diagnostic dilemma of chromosomal abnormalities in the Niger Delta area of Nigeria; Is prenatal diagnosis worthwhile?
Main Article Content
Keywords
Prevalence, Chromosomal abnormalities, Prenatal diagnosis, Tertiary health facility, Niger Delta Region, Nigeria
Abstract
Background: Early detection of increasing numbers of cases of chromosomal abnormalities (aneuploides) at the Rivers State University Teaching Hospital (RSUTH) in the Niger Delta will enhance appropriate counseling of patients and early termination of the affected pregnancies. The study aimed to ascertain the prevalence of aneuploides at the RSUTH and to determine the necessity for early prenatal diagnosis in the Niger Delta.
Methodology: This was a prospective cross-sectional study carried out over a three-year period (01/01/2018 – 01/01/2021) at the RSUTH, Nigeria. Newborn babies delivered at 28 weeks and above were assessed at birth for the phenotypes of aneuploidy and associated birth defects. A convenient sampling method was used to recruit all the babies with chromosomal abnormalities and their mothers. Data including that of socio-demographic, obstetric characteristics, and the fetuses were taken and analyzed using Statistical Package for Social Sciences Version 23 (SPSS version 23). Quantitative variables were summarized using means and standard deviation while qualitative variables were expressed as frequencies and proportions.
Results: The total number of babies that were delivered by the 5868 participants in the study was 6078, out of which 10 cases of aneuploides were identified – 3 cases of trisomy 18 and 7 cases of Trisomy 21. The prevalence of chromosomal abnormalities at birth at the RSUTH was 0.165% of the total births, 1:2000 and 1:654 for T18 and T21 respectively. 1:654 mothers had babies with chromosomal abnormalities, 1:2000 and 1:833 for T18 and T21 respectively.
Conclusion: The prevalence of chromosomal abnormalities at birth at the RSUTH of 0.165% represented a gross underestimation because the diagnosis was based on the outward phenotypical appearance of the neonates and it was made not from babies delivered at 20 weeks and above as practiced in Europe and other countries, but from 28 weeks. Prenatal diagnosis was therefore highly recommended in the Niger Delta.
References
2. Kelly M, Robinson BW, Moore JW. Trisomy 18 in a 20-year-old woman. Am J Med Genet. 2002; 112(4):397-9.
3. Lebel RR, Roberson J, Van Dyke DL. Regarding trisomy 18. Am J Med Genet A. 2006; 140(9):964-5.
4. Rasmussen SA, Wong LY, Yang Q, May KM, Friedman JM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics. 2003 Apr. 111(4 Pt 1):777-84.
5. Embleton ND, Wyllie JP, Wright MJ, et al. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed. 1996; 75(1):F38-41.
6. Lejeune J. Le mongolisme. Premier example d'aberration autosomique humaine. Ann Genet. 1959. 1:41-10.
7. Jacobs PA, Baikie AG, Court-Brown WM, Strong JA. The somatic chromosomes in mongolism. Lancet. 1959; 1(7075):710.
8. Peterson MB, Mikkelsen M. Nondisjunction in trisomy 21: origin and mechanisms. Cytogenet Cell Genet. 2000; 91:199-203.
9. Down JL. Observations on an ethnic classification of idiots. 1866. Ment Retard. 1995; 33(1):54-6.
10. LEJEUNE J, GAUTIER M, TURPIN R. Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci. 1959;248(11):1721-2.
11. Kypros H. Nicolaides. The 11–13+6 weeks scan. Fetal Medicine Foundation, London 2004.
12. Zhang H, Wang S, Feng C, Zhao H, Zhang W, Sun Y and Yang H (2023) Chromosomal abnormalities and structural defects in fetuses with increased nuchal translucency at a Chinese tertiary medical center. Front. Med. 2023;10:1158554.
13. Kagan K O, Sonek J, Kozlowski P Antenatal screening for chromosomal abnormalities Archives of Gynecology and Obstetrics 2022, 305:825–835
14. Becker DA, Tang Y, Jacobs AP, Biggio JR, et al. Sensitivity of prenatal ultrasound for detection of trisomy 18. J Matern Fetal Neonatal Med. 2018; 1-7.
15. Nieuwenhuis-Mark RE. Diagnosing Alzheimer’s dementia in Down syndrome: Problems and possible solutions. Res Dev Disabil. 2009. 30(5):827-838.
16. Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009; 156(2):189-93.
17. 15Vis JC, Duffels MG, Winter MM, Weijerman ME et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res. 2009 May. 53(5):419-25.
18. 16Lanfranchi S, Carretti B, Spanò G, Cornoldi C. A specific deficit in visuospatial simultaneous working memory in Down syndrome. J Intellect Disabil Res. 2009; 53(5):474-83.
19. Levorato MC, Roch M, Beltrame R. Text comprehension in Down syndrome: the role of lower and higher level abilities. Clin Linguist Phon. 2009;23(4):285-300.
20. Salomon LJ, Bernard M, Amarsy R, Bernard JP, Ville Y. The impact of crown-rump length measurement error on combined Down syndrome screening: a simulation study. Ultrasound Obstet Gynecol. 2009; 33(5):506-11.
21. Christina A. Hecht, Ernest B. Hook. Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening. American journal of medical genetics 1996; 62(4):376-85.
22. Snijders RJM, Sundberg K, Holzgreve W, Nicolaides KH et al. Maternal age- and gestation-specific risk for trisomy 21. Ultrasound Obstet Gynecol 1999; 13:167–170.
23. Shanske AL. Trisomy 18 in a second 20-year-old woman. Am J Med Genet A. 2006; 140(9):966-7.
24. Nicolaides KH. The 11–13+6 weeks scan. Fetal Medicine Foundation, London 2004.
25. Rasmussen SA, Wong LY, Yang Q, May KM et al. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics. 2003; 111(4 Pt 1):777-84.
26. Embleton ND, Wyllie JP, Wright MJ, et al. Natural history of trisomy 18. Arch Dis Child Fetal Neonatal Ed. 1996;75(1):F38-41.
27. Tompkins, AB (1964). Down’s Syndrome in Nigerian Children. Journal of Medical Genetics 1964. 1:115- 117
28. Adeyokunnu A.A. The incidence of Down’s syndrome in Nigeria. Journal of Medical Genetics 1982. 19:277-279.
29. Oloyede OAO. Down syndrome screening in Nigeria. International Journal of Gynaecology and Obstetrics 2008; 100(1):88-89.
30. Oloyede OAO, Mkpe Abbey, Oloyede AA, Nwachukwu O. Fetal nuchal translucency scan in Nigeria. Pan Afr Med. J. 2014; 18: 62.
31. Sulaiman, B, Shehu CE, Panti AA, Saidu SA et al. Prevalence and Outcome of Increased Nuchal Translucency in Usmanu Danfodiyo University Teaching Hospital, Sokoto, Nigeria. Nigerian Journal of Clinical Practice June 2020;23(6):864-869.
32. The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) Congenital Anomaly Official Statistics Report, 2020 - NHS Digital.
33. Shuangbo Xia1, Chao Meng, Xiao Cheng, Duoduo Wang et al. Prevalence and trends of chromosomal abnormalities in Haidian District, Beijing, China, from 2013 to 2022. Chinese Center for Disease Control and Prevention (CCDC) Weekly; 5:36
34. Diana Wellesley, Helen Dolk, Patricia A Boyd, Ruth Greenlees, Martin Haeusler4, Vera Nelen, et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. European Journal of Human Genetics 2012;20: 521–526.
35. Sherod C, Sebire CNJ, Soares W, Snijders RJM, Nicolaides KH. Prenatal diagnosis of trisomy 18 at the 10–14-week ultrasound scan December 1997;100(6):387-390.
36. KAGAN AKO, WRIGHT W, MAIZ N, PANDEVA I, NICOLAIDES KH. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin, and pregnancy-associated plasma protein. A. Ultrasound Obstet Gynecol 2008;32: 488 – 492
37. The Fetal Medicine Foundation. https://fetal,medicine.org. Last visited 25/05/2024.